Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis

Fig. 7

Silencing of circRFX3 blocked tumorigenesis of glioma in vivo. A After sh-circRFX3#1 or sh-NC transfected A172 cells were injected into the mice, tumor volume was monitored every 7 days. B Tumor weight was examined on day 35. C The levels of circRFX3, miR-1179, miR-1229 and VASP mRNA in the collected tumor tissues were measured by qRT-PCR assay. D The protein level of VASP in the collected tumor tissues was measured using western blot assay. **P < 0.01

Back to article page